BOOSTING OVARIAN TUMORS' RESPONSES TO IMMUNOTHERAPY WITH UNIQUE SWITCHABLE SPLIT SUPERANTIGEN FUSED WITH ANTIBODIES TARGETING BINARY TUMOR-SPECIFIC RECEPTORS
$405,000FY2025Defense Health AgencyDOD
Panorama Research Incorporated
Panorama Research Incorporated